Fintan R Steele

Title: Fintan R Steele: Innovator in Neurotrophic Factors

Introduction

Fintan R Steele is a notable inventor based in Washington, DC. He has made significant contributions to the field of neurotrophic factors, holding a total of 4 patents. His work focuses on the development of therapeutic methods and compositions that have the potential to treat various medical conditions.

Latest Patents

One of Steele's latest patents is related to a purified retinal pigmented epithelium derived neurotrophic factor composition. This invention includes a method for purifying such a factor and a recombinant DNA molecule that encodes the retinal pigmented epithelium derived neurotrophic factor. The invention also encompasses methods for treating tumors, ocular diseases, nerve injuries, and conditions resulting from the activity of serine proteases through the administration of PEDF. Another significant patent involves nucleic acids encoding the neurotrophic protein known as pigment epithelium derived factor (PEDF) and its variants. The effects and uses of these variants on neuronal differentiation, neuron survival, and glial inhibition are also described.

Career Highlights

Fintan R Steele works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His career has been marked by a commitment to advancing medical science through innovative research and development.

Collaborations

Steele has collaborated with notable colleagues in his field, including Joyce Tombran-Tink and Gerald J Chader. Their combined expertise has contributed to the advancement of research in neurotrophic factors.

Conclusion

Fintan R Steele's work in the field of neurotrophic factors exemplifies the impact of innovation on medical science. His patents and collaborations highlight the importance of research in developing new therapeutic methods.